SATB1 collaborates with loss of p16 in cellular transformation

Oncogene

Volumn 32, Issue 48, 2013, Pages 5492-5500

  Agrelo, R ^a,b   Kishimoto, H ^b,c,d   Novatchkova, M ^b   Peraza, V ^a   Paolino, M ^b   Souabni, A ^b   Wutz, A ^b,d,e  

^a INSTITUT PASTEUR DE MONTEVIDEO   (Uruguay)

^b RESEARCH INSTITUTE OF MOLECULAR PATHOLOGY   (Austria)

^c UNIVERSITY OF TSUKUBA   (Japan)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e ETH ZURICH   (Switzerland)

Author keywords

Cell cycle; E2F; P16; RB; SATB1; Senescence; Tumor

Indexed keywords

CYCLIN E; PROTEIN P107; PROTEIN P130; PROTEIN P16; RETINOBLASTOMA PROTEIN;

ARTICLE; CELL CYCLE ARREST; CELL TRANSFORMATION; CONTROLLED STUDY; FIBROBLAST; G1 PHASE CELL CYCLE CHECKPOINT; GENE; GENE EXPRESSION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEPLETION; RETINOBLASTOMA; SENESCENCE; SPECIAL AT RICH BINDING GENE 1;

ANIMALS; CELL AGING; CELL CYCLE; CELL LINE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CYCLIN-DEPENDENT KINASE INHIBITOR P16; E2F TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; HUMANS; MATRIX ATTACHMENT REGION BINDING PROTEINS; MICE; MUTATION; RETINOBLASTOMA;

EID: 84889096668     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2013.158     Document Type: Article

References (45)

1. de Belle I, Cai S, Kohwi-Shigematsu T. The genomic sequences bound to special AT-rich sequence-binding protein 1 (SATB1) in vivo in Jurkat T cells are tightly associated with the nuclear matrix at the bases of the chromatin loops. J Cell Biol 1998; 141: 335-348
2. Dickinson LA, Joh T, Kohwi Y, Kohwi-Shigematsu T. A tissue-specific MAR/SAR DNA-binding protein with unusual binding site recognition. Cell 1992; 70: 631-645
3. Alvarez JD, Yasui DH, Niida H, Joh T, Loh DY, Kohwi-Shigematsu T. The MARbinding protein SATB1 orchestrates temporal and spatial expression of multiple genes during T-cell development. Genes Dev 2000; 14: 521-535
4. Asanoma K, Kubota K, Chakraborty D, Renaud SJ, Wake N, Fukushima K et al. SATB homeobox proteins regulate trophoblast stem cell renewal and differentiation. J Biol Chem 2012; 287: 2257-2268
5. Savarese F, Davila A, Nechanitzky R, De La Rosa-Velazquez I, Pereira CF, Engelke R et al. Satb1 and Satb2 regulate embryonic stem cell differentiation and nanog expression. Genes Dev 2009; 23: 2625-2638
6. Cai S, Lee CC, Kohwi-Shigematsu T. SATB1 packages densely looped, transcriptionally active chromatin for coordinated expression of cytokine genes. Nat Genet 2006; 38: 1278-1288
7. Cai S, Han HJ, Kohwi-Shigematsu T. Tissue-specific nuclear architecture and gene expression regulated by SATB1. Nat Genet 2003; 34: 42-51
8. Agrelo R, Souabni A, Novatchkova M, Haslinger C, Leeb M, Komnenovic V et al. SATB1 defines the developmental context for gene silencing by Xist in lymphoma and embryonic cells. Dev Cell 2009; 16: 507-516
9. Yasui D, Miyano M, Cai S, Varga-Weisz P, Kohwi-Shigematsu T. SATB1 targets chromatin remodelling to regulate genes over long distances. Nature 2002; 419: 641-645
10. Pavan Kumar P, Purbey PK, Sinha CK, Notani D, Limaye A, Jayani RS et al. Phosphorylation of SATB1, a global gene regulator, acts as a molecular switch regulating its transcriptional activity in vivo. Mol Cell 2006; 22: 231-243
11. Purbey PK, Singh S, Notani D, Kumar PP, Limaye AS, Galande S. Acetylationdependent interaction of SATB1 and CtBP1 mediates transcriptional repression by SATB1. Mol Cell Biol 2009; 29: 1321-1337
12. Tan JA, Sun Y, Song J, Chen Y, Krontiris TG, Durrin LK. SUMO conjugation to the matrix attachment region-binding protein, special AT-rich sequence-binding protein-1 (SATB1), targets SATB1 to promyelocytic nuclear bodies where it undergoes caspase cleavage. J Biol Chem 2008; 283: 18124-18134
13. Notani D, Gottimukkala KP, Jayani RS, Limaye AS, Damle MV, Mehta S et al. Global regulator SATB1 recruits beta-catenin and regulates T(H)2 differentiation in Wnt-dependent manner. PLoS Biol 2010; 8: e1000296
14. Beyer M, Thabet Y, Muller RU, Sadlon T, Classen S, Lahl K et al. Repression of the genome organizer SATB1 in regulatory T cells is required for suppressive function and inhibition of effector differentiation. Nat Immunol 2011; 12: 898-907
15. Fessing MY, Mardaryev AN, Gdula MR, Sharov AA, Sharova TY, Rapisarda V et al. p63 regulates Satb1 to control tissue-specific chromatin remodeling during development of the epidermis. J Cell Biol 2011; 194: 825-839
16. Han HJ, Russo J, Kohwi Y, Kohwi-Shigematsu T. SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis. Nature 2008; 452: 187-193
17. Cheng C, Lu X, Wang G, Zheng L, Shu X, Zhu S et al. Expression of SATB1 and heparanase in gastric cancer and its relationship to clinicopathologic features. Apmis 2010; 118: 855-863
18. Lu X, Cheng C, Zhu S, Yang Y, Zheng L, Wang G et al. SATB1 is an independent prognostic marker for gastric cancer in a Chinese population. Oncol Rep 2010; 24: 981-987
19. Zhao XD, Ji WY, Zhang W, He LX, Yang J, Liang HJ et al. Overexpression of SATB1 in laryngeal squamous cell carcinoma. ORL J Otorhinolaryngol Relat Spec 2010; 72: 1-5
20. Meng WJ, Yan H, Zhou B, Zhang W, Kong XH, Wang R et al. Correlation of SATB1 overexpression with the progression of human rectal cancer. Int J Colorectal Dis 2011; 27: 143-150
21. Chen H, Takahara M, Oba J, Xie L, Chiba T, Takeuchi S et al. Clinicopathologic and prognostic significance of SATB1 in cutaneous malignant melanoma. J Dermatol Sci 2011; 64: 39-44
22. McInnes N, Sadlon TJ, Brown CY, Pederson S, Beyer M, Schultze JL et al. FOXP3 and FOXP3-regulated microRNAs suppress SATB1 in breast cancer cells. Oncogene 2011; 31: 1045-1054
23. Yamayoshi A, Yasuhara M, Galande S, Kobori A, Murakami A. Decoy-DNA against special AT-rich sequence binding protein 1 inhibits the growth and invasive ability of human breast cancer. Oligonucleotides 2011; 21: 115-121
24. Iorns E, Hnatyszyn HJ, Seo P, Clarke J, Ward T, Lippman M. The role of SATB1 in breast cancer pathogenesis. J Natl Cancer Inst 2010; 102: 1284-1296
25. Kohwi-Shigematsu T, Han HJ, Russo J, Kohwi Y. Re: The role of SATB1 in breast cancer pathogenesis. J Natl Cancer Inst 2010; 102: 1879-1880
26. Hanker LC, Karn T, Mavrova-Risteska L, Ruckhaberle E, Gaetje R, Holtrich U et al. SATB1 gene expression and breast cancer prognosis. Breast 2010; 20: 309-313
27. Odell A, Askham J, Whibley C, Hollstein M. How to become immortal: Let MEFs count the ways. Aging (Albany NY) 2010; 2: 160-165
28. Kim H, You S, Farris J, Foster LK, Foster DN. Post-transcriptional inactivation of p53 in immortalized murine embryo fibroblast cells. Oncogene 2001; 20: 3306-3310
29. Fiorentino FP, Symonds CE, Macaluso M, Giordano A. Senescence and p130/Rbl2: A new beginning to the end. Cell Res 2009; 19: 1044-1051
30. Harb G, Vasavada RC, Cobrinik D, Stewart AF. The retinoblastoma protein and its homolog p130 regulate the G1/S transition in pancreatic beta-cells. Diabetes 2009; 58: 1852-1862
31. Alcorta DA, Xiong Y, Phelps D, Hannon G, Beach D, Barrett JC. Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts. Proc Natl Acad Sci USA 1996; 93: 13742-13747
32. Meyyappan M, Wong H, Hull C, Riabowol KT. Increased expression of cyclin D2 during multiple states of growth arrest in primary and established cells. Mol Cell Biol 1998; 18: 3163-3172
33. Kim WY, Sharpless NE. The regulation of INK4/ARF in cancer and aging. Cell 2006; 127: 265-275
34. Takahashi A, Ohtani N, Hara E. Irreversibility of cellular senescence: Dual roles of p16INK4a/Rb-pathway in cell cycle control. Cell Div 2007; 2: 10
35. Sage J.Mulligan GJ, Attardi LD, Miller A, Chen S, Williams B et al. Targeted disruption of the three Rb-related genes leads to loss of G(1) control and immortalization. Genes Dev 2000; 14: 3037-3050
36. Sellers WR, Novitch BG, Miyake S, Heith A, Otterson GA, Kaye FJ et al. Stable binding to E2F is not required for the retinoblastoma protein to activate transcription, promote differentiation, and suppress tumor cell growth. Genes Dev 1998; 12: 95-106
37. Conklin JF, Sage J. Keeping an eye on retinoblastoma control of human embryonic stem cells. J Cell Biochem 2009; 108: 1023-1030
38. White J, Dalton S. Cell cycle control of embryonic stem cells. Stem Cell Rev 2005; 1: 131-138
39. Geng Y, Eaton EN, Picon M, Roberts JM, Lundberg AS, Gifford A et al. Regulation of cyclin E transcription by E2Fs and retinoblastoma protein. Oncogene 1996; 12: 1173-1180
40. Quesnel B, Preudhomme C, Lepelley P, Hetuin D, Vanrumbeke M, Bauters F et al. Transfer of p16inka/CDKN2 gene in leukaemic cell lines inhibits cell proliferation. Br J Haematol 1996; 95: 291-298
41. Kim M, Katayose Y, Rojanala L, Shah S, Sgagias M, Jang L et al. Induction of apoptosis in p16INK4A mutant cell lines by adenovirus-mediated overexpression of p16INK4A protein. Cell Death Differ 2000; 7: 706-711
42. Ordinario E, Han HJ, Furuta S, Heiser LM, Jakkula LR, Rodier F et al. ATM suppresses SATB1-induced malignant progression in breast epithelial cells. PloS One 2012; 7: e51786
43. Khan MZ, Brandimarti R, Shimizu S, Nicolai J, Crowe E, Meucci O. The chemokine CXCL12 promotes survival of postmitotic neurons by regulating Rb protein. Cell Death Differ 2008; 15: 1663-1672
44. Leeb M, Wutz A. Ring1B is crucial for the regulation of developmental control genes and PRC1 proteins but not X inactivation in embryonic cells. J Cell Biol 2007; 178: 219-229
45. Morita S, Kojima T, Kitamura T. Plat-E: An efficient and stable system for transient packaging of retroviruses. Gene Therapy 2000; 7: 1063-1066